Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4264]

SABCS 2013: Exercise improves drug-associated joint pain in breast cancer survivors

SABCS 2013: Exercise improves drug-associated joint pain in breast cancer survivors

SABCS 2013: PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant

SABCS 2013: PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant

SABCS 2013: Antihormone therapy anastrozole may provide new option for breast cancer prevention

SABCS 2013: Antihormone therapy anastrozole may provide new option for breast cancer prevention

SABCS 2013: Results from NeoALTTO trial indicate breast cancer patients who had pathologic complete response had improved survival

SABCS 2013: Results from NeoALTTO trial indicate breast cancer patients who had pathologic complete response had...

Anastrozole cuts breast cancer cases by more than 50% in high risk women

Anastrozole cuts breast cancer cases by more than 50% in high risk women

Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed

Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed

SABCS 2013: Patients with metastatic breast cancer may not benefit from surgery and radiation after chemotherapy

SABCS 2013: Patients with metastatic breast cancer may not benefit from surgery and radiation after chemotherapy

SABCS 2013: Avoiding radiotherapy is an option for some older patients with breast cancer

SABCS 2013: Avoiding radiotherapy is an option for some older patients with breast cancer

SABCS 2013: Study identifies highly effective treatment option for patients with HER2- positive breast cancer

SABCS 2013: Study identifies highly effective treatment option for patients with HER2- positive breast cancer

SABCS 2013: High levels of immune cells in tumours may identify breast cancer patients most likely to benefit from trastuzumab

SABCS 2013: High levels of immune cells in tumours may identify breast cancer patients most likely to benefit from...

More from ecancer